Personalized Psoriasis Treatment:
A Case Study On How AI
Accelerated Biomarker Discovery

Personalized Psoriasis Treatment: A Case Study On How AI Accelerated Biomarker Discovery

Our client’s requirement

A major European pharmaceutical company wanted to personalize treatment for psoriasis patients using their successful drug, Cosentyx. Their challenge was optimizing this process by identifying patient-specific biomarkers that could predict treatment response. Here’s why traditional methods weren’t ideal:

  • Time-consuming data analysis: Manually sifting through large datasets was slow and prone to errors.
  • Missing hidden patterns: Traditional methods might miss important clues for identifying biomarkers.
  • Subjectivity in analysis: Manual analysis could lead to inconsistent selection of biomarkers across different studies.

Our approach

Excelra stepped in, partnering with the leading pharmaceutical company to unlock the power of artificial intelligence (AI) and machine learning (ML). We envisioned a future where AI could sift through vast datasets, uncovering hidden connections and identifying the most relevant biomarkers for predicting Cosentyx response.

Here’s a glimpse into our innovative approach:

  • Data Deluge: We meticulously collected and integrated a wealth of patient data, encompassing clinical trial information, genetic profiles, and real-world treatment outcomes.
  • AI Uncovers the Unseen: Cutting-edge machine learning algorithms were employed to analyze this comprehensive dataset. These algorithms were trained to recognize complex patterns and relationships within the data, unearthing potential biomarkers that traditional methods might have missed.
  • Refining the Raw Signal: The raw output from the AI models was rigorously evaluated and filtered by a team of data scientists and medical experts. This ensured only the most promising and clinically relevant biomarkers were identified for further investigation.

Intrigued by the results? The full case study delves deeper into the specific AI models used, the identified biomarkers, and the potential impact on personalized treatment for psoriasis patients. Discover how Excelra and the client are paving the way for a future of data-driven medicine!

Download case study